Dehydroepiandrosterone Sulfate in Patients with Rheumatoid Arthritis
Authors:
- Erik J. GiltayEGErik J. Giltay
- Dirkjan VAN SchaardenburgDSDirkjan VAN Schaardenburg
- 1 June 1999
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 876 (1) , 152-154
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Serum dehydroepiandrosterone sulphate levels in patients with early rheumatoid arthritis: positive association with C-reactive protein, but not with HLA-DR genotype.Rheumatology, 1998
- Effects of dehydroepiandrosterone administration on disease activity in patients with rheumatoid arthritis.Rheumatology, 1998
- A RANDOMIZED TRIAL OF TESTOSTERONE THERAPY IN MALES WITH RHEUMATOID ARTHRITISRheumatology, 1996
- A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activityClinical Rheumatology, 1996
- Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytesThe Journal of Clinical Endocrinology & Metabolism, 1995
- Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunologic and microvascular systemsSeminars in Arthritis and Rheumatism, 1995
- Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1993
- Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cellsClinical Immunology and Immunopathology, 1991
- Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cellsBlood, 1991
- The control of adrenal androgen secretionJournal of Endocrinology, 1991